Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA

Purpose of Review: This manuscript aims to review (for the first time) studies describing NGS sequencing of preeclampsia (PE) women’s DNA. Recent Findings: Describing markers for the early detection of PE is an essential task because, although associated molecular dysfunction begins early on during...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2020
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23809
Acceso en línea:
https://doi.org/10.1007/s11906-020-01039-z
https://repository.urosario.edu.co/handle/10336/23809
Palabra clave:
Dna
Acvr2a gene
Allele
Ano9 gene
Dna sequencing
Environmental factor
Gene
Gene mutation
Genetic association
Genetic code
Genetic variation
High throughput sequencing
Human
Khdc3l gene
Maternal plasma
Molecular pathology
Nonhuman
Nrlp14 gene
Nrlp2 gene
Placenta development
Preeclampsia
Review
Tmtc1 gene
Tp53bp1 gene
Trim28 gene
Zfr2 gene
Genetic biomarker
Molecular medicine
Next-generation sequencing (ngs)
Preeclampsia
Rights
License
Abierto (Texto Completo)
id EDOCUR2_2803742c4849c7a5d99dcc87cf9751d2
oai_identifier_str oai:repository.urosario.edu.co:10336/23809
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 79782770600060cd606-a1b2-4ff3-8204-0b5b56af7750-12020-05-26T00:05:36Z2020-05-26T00:05:36Z2020Purpose of Review: This manuscript aims to review (for the first time) studies describing NGS sequencing of preeclampsia (PE) women’s DNA. Recent Findings: Describing markers for the early detection of PE is an essential task because, although associated molecular dysfunction begins early on during pregnancy, the disease’s clinical signs usually appear late in pregnancy. Although several biochemical biomarkers have been proposed, their use in clinical environments is still limited, thereby encouraging research into PE’s genetic origin. Hundreds of genes involved in numerous implantation- and placentation-related biological processes may be coherent candidates for PE aetiology. Next-generation sequencing (NGS) offers new technical possibilities for PE studying, as it enables large genomic regions to be analysed at affordable cost. This technique has facilitated the description of genes contributing to the molecular origin of a significant amount of monogenic and complex diseases. Regarding PE, NGS of DNA has been used in familial and isolated cases, thereby enabling new genes potentially related to the phenotype to be proposed. Summary: For a better understanding of NGS, technical aspects, applications and limitations are presented initially. Thereafter, NGS studies of DNA in familial and non-familial cases are described, including pitfalls and positive findings. The information given here should enable scientists and clinicians to analyse and design new studies permitting the identification of novel clinically useful molecular PE markers. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.application/pdfhttps://doi.org/10.1007/s11906-020-01039-z1522641715343111https://repository.urosario.edu.co/handle/10336/23809engSpringerNo. 4Current Hypertension ReportsVol. 22Current Hypertension Reports, ISSN:15226417, 15343111, Vol.22, No.4 (2020)https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081592717&doi=10.1007%2fs11906-020-01039-z&partnerID=40&md5=40d06a8a1113baaf2530ff21a64a4034Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURDnaAcvr2a geneAlleleAno9 geneDna sequencingEnvironmental factorGeneGene mutationGenetic associationGenetic codeGenetic variationHigh throughput sequencingHumanKhdc3l geneMaternal plasmaMolecular pathologyNonhumanNrlp14 geneNrlp2 genePlacenta developmentPreeclampsiaReviewTmtc1 geneTp53bp1 geneTrim28 geneZfr2 geneGenetic biomarkerMolecular medicineNext-generation sequencing (ngs)PreeclampsiaExploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNAarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Laissue, PaulVaiman, Daniel10336/23809oai:repository.urosario.edu.co:10336/238092022-05-02 07:37:14.807529https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
title Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
spellingShingle Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
Dna
Acvr2a gene
Allele
Ano9 gene
Dna sequencing
Environmental factor
Gene
Gene mutation
Genetic association
Genetic code
Genetic variation
High throughput sequencing
Human
Khdc3l gene
Maternal plasma
Molecular pathology
Nonhuman
Nrlp14 gene
Nrlp2 gene
Placenta development
Preeclampsia
Review
Tmtc1 gene
Tp53bp1 gene
Trim28 gene
Zfr2 gene
Genetic biomarker
Molecular medicine
Next-generation sequencing (ngs)
Preeclampsia
title_short Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
title_full Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
title_fullStr Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
title_full_unstemmed Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
title_sort Exploring the Molecular Aetiology of Preeclampsia by Massive Parallel Sequencing of DNA
dc.subject.keyword.spa.fl_str_mv Dna
Acvr2a gene
Allele
Ano9 gene
Dna sequencing
Environmental factor
Gene
Gene mutation
Genetic association
Genetic code
Genetic variation
High throughput sequencing
Human
Khdc3l gene
Maternal plasma
Molecular pathology
Nonhuman
Nrlp14 gene
Nrlp2 gene
Placenta development
Preeclampsia
Review
Tmtc1 gene
Tp53bp1 gene
Trim28 gene
Zfr2 gene
Genetic biomarker
Molecular medicine
Next-generation sequencing (ngs)
Preeclampsia
topic Dna
Acvr2a gene
Allele
Ano9 gene
Dna sequencing
Environmental factor
Gene
Gene mutation
Genetic association
Genetic code
Genetic variation
High throughput sequencing
Human
Khdc3l gene
Maternal plasma
Molecular pathology
Nonhuman
Nrlp14 gene
Nrlp2 gene
Placenta development
Preeclampsia
Review
Tmtc1 gene
Tp53bp1 gene
Trim28 gene
Zfr2 gene
Genetic biomarker
Molecular medicine
Next-generation sequencing (ngs)
Preeclampsia
description Purpose of Review: This manuscript aims to review (for the first time) studies describing NGS sequencing of preeclampsia (PE) women’s DNA. Recent Findings: Describing markers for the early detection of PE is an essential task because, although associated molecular dysfunction begins early on during pregnancy, the disease’s clinical signs usually appear late in pregnancy. Although several biochemical biomarkers have been proposed, their use in clinical environments is still limited, thereby encouraging research into PE’s genetic origin. Hundreds of genes involved in numerous implantation- and placentation-related biological processes may be coherent candidates for PE aetiology. Next-generation sequencing (NGS) offers new technical possibilities for PE studying, as it enables large genomic regions to be analysed at affordable cost. This technique has facilitated the description of genes contributing to the molecular origin of a significant amount of monogenic and complex diseases. Regarding PE, NGS of DNA has been used in familial and isolated cases, thereby enabling new genes potentially related to the phenotype to be proposed. Summary: For a better understanding of NGS, technical aspects, applications and limitations are presented initially. Thereafter, NGS studies of DNA in familial and non-familial cases are described, including pitfalls and positive findings. The information given here should enable scientists and clinicians to analyse and design new studies permitting the identification of novel clinically useful molecular PE markers. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.
publishDate 2020
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:05:36Z
dc.date.available.none.fl_str_mv 2020-05-26T00:05:36Z
dc.date.created.spa.fl_str_mv 2020
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1007/s11906-020-01039-z
dc.identifier.issn.none.fl_str_mv 15226417
15343111
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23809
url https://doi.org/10.1007/s11906-020-01039-z
https://repository.urosario.edu.co/handle/10336/23809
identifier_str_mv 15226417
15343111
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationIssue.none.fl_str_mv No. 4
dc.relation.citationTitle.none.fl_str_mv Current Hypertension Reports
dc.relation.citationVolume.none.fl_str_mv Vol. 22
dc.relation.ispartof.spa.fl_str_mv Current Hypertension Reports, ISSN:15226417, 15343111, Vol.22, No.4 (2020)
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85081592717&doi=10.1007%2fs11906-020-01039-z&partnerID=40&md5=40d06a8a1113baaf2530ff21a64a4034
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Springer
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167577801261056